Novamind (NM.C) announced they are opening four new Cedar Psychiatric clinics, doubling the number of clinics in there network. The expanded capacity for the new clinics is intended to…
Cedar Clinical Research
Novamind (NM.C) announced that their wholly-owned subsidiary, Cedar Clinical Research (CCR), has been selected by Merck to be a key research site for a clinical trial focused on treatment-resistant…